Diagnosing and treating Crohn’s disease as early as possible can help prevent or stave off serious complications like perianal Crohn’s disease and colon cancer.

As scientists question the rise in early colon cancer cases, a new study is offering some potential answers. Colored scanning electron micrograph (SEM) of a macrophage white blood cell (center) that ...

(WSVN) - It’s called the “silent surge” — men in their 30s being diagnosed with colon cancer. 7Investigates why their symptoms are often misdiagnosed. Here’s 7’s Courtney Allen. Thirty-four-year-old ...

Colorectal cancer — which includes cancer of the colon and of the rectum — is considered early onset when diagnosed in people under the age of 50. While the majority of diagnoses are still among ...

Cases of colorectal cancer in younger adults are climbing worldwide, driven by lifestyle changes and inherited genetic risks. Diet, obesity, and lack of early screening are playing a major role in ...

DEAR DR. ROACH: I had a colonoscopy performed, and my doctor noted that I had a “tortured colon.” His answer was somewhat vague when I asked what caused this condition and if there was anything I ...

Many people associate colon cancer with old age, but that's not the case anymore, as the number of young people being diagnosed is on the rise. According to the American Cancer Society, an estimated ...

What Is Crohn’s Constipation? You likely have constipation if it's hard for you to poop and you're having fewer bowel movements than you normally do. The same is true whether or not you have Crohn’s ...

Treatment with a GLP-1 receptor agonist (RA) may offer a survival advantage in patients with colon cancer and obesity. In a real-world analysis of nearly 7000 patients with colon cancer, those taking ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and Mounjaro) had substantially lower five-year death rates than those not using ...

The three-dimensional (3D) reconstruction of bowel strictures in Crohn’s disease can enhance patient understanding and facilitate multidisciplinary decision-making, offering a promising tool in ...